A Questionnaire Investigation of Anxiety and Depression in Early Dementia

Wands, Kim; Merskey, Harold; Hachinski, Vladimir; Fisman, Michael; Fox, Hannah; Boniferro, Mary

doi:10.1111/j.1532-5415.1990.tb02404.x

Cited by 72 publications

(40 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the prevalence rates found in the present study are much lower than those found in earlier research [3,6,[9][10][11][12]41] , which could be due to the relatively high level of education in the group diagnosed with AD.…”

Section: Discussioncontrasting

confidence: 56%

Symptoms of Anxiety and Depression in the Course of Cognitive Decline

Bierman

Comijs

Jonker

et al. 2007

Dement Geriatr Cogn Disord

View full text Add to dashboard Cite

Background/Aims: Anxiety and depression are common inpatients with cognitive decline and Alzheimer’s disease (AD), and recognition and treatment of these symptoms can improve their quality of life. The present study investigates anxiety and depression in different phases of cognitive decline. Methods: The sample consisted of five groups of elderly people in different phases of cognitive decline; four from a community-based sample (Longitudinal Aging Study Amsterdam), and one group of elderly people diagnosed with AD. ANOVAs were performed to investigate group differences in the severity and prevalence of anxiety and depression, and comorbid anxiety and depressive symptoms. Results: The prevalence rates of anxiety, comorbid anxiety and depressive symptoms and depressive symptoms follow a pattern of an increasing prevalence as cognitive performance declines and a decrease in the prevalence when cognitive functioning is severely impaired. AD patients report fewest anxiety symptoms. Conclusion: We found that the prevalence of anxiety symptoms, depressive symptoms and comorbid anxiety and depressive symptoms seems to increase in the early phase of cognitive decline, and decreases as cognitive functioning further declines. Elderly diagnosed with AD report less anxiety as expected, probably due to lack of insight caused by AD.

show abstract

Section: Discussioncontrasting

confidence: 56%

Symptoms of Anxiety and Depression in the Course of Cognitive Decline

Bierman

Comijs

Jonker

et al. 2007

Dement Geriatr Cogn Disord

View full text Add to dashboard Cite

show abstract

“…For instance, while a study of elderly adults discovered that at follow-up, those with depressive symptoms were more likely to have dementia relative to those without such symptoms (Jorm, 2001), other research reported that the presentation of depressive symptoms coincided with or followed the onset of dementia, rather than preceding it (Butters et al, 2008;Korczyn and Halperin, 2009). Anxiety disorders are also frequently observed in individuals with dementia, with prevalence rates ranging between 17% and 38% (Ballard et al, 1996;Ballard et al, 2000;Ballard et al 1994;Wands et al, 1990).…”

Section: Why Is Music a Potentially Useful Intervention For People LImentioning

confidence: 99%

An exploratory study of the impact of group singing activities on lucidity, energy, focus, mood and relaxation for persons with dementia and their caregivers

Davidson

Almeida

2014

Psych Well-Being

View full text Add to dashboard Cite

Background: It is known that persons with dementia (PWD) suffer a variety of difficulties, with increased agitation as well as lowered mood, focus and lucidity being amongst their greatest challenges. Caregivers are also affected and report increased stress levels, as well as lower energy, mood and focus. The aim of the current study was to explore whether engagement in a singing program could result in improvement in these variables for both PWD and Caregivers.

show abstract

“…[117][118][119][120][121] It has not been validated in patients with significant cognitive impairment and has only rarely been used in this population. 122,123 The scale is in the public domain (see, for example, Table 3 located in Supplementary Material), but for use in large scale research projects, purchase of the scale from the publisher is required. 124 It has been validated and used in many countries in all parts of the world.…”

Section: Depression In Non-pd Patientsmentioning

confidence: 99%

Depression rating scales in Parkinson's disease: Critique and recommendations

Schrag¹,

Barone²,

Brown³

et al. 2007

Movement Disorders

586

348

View full text Add to dashboard Cite

Depression is a common comorbid condition in Parkinson's disease (PD) and a major contributor to poor quality of life and disability. However, depression can be difficult to assess in patients with PD due to overlapping symptoms and difficulties in the assessment of depression in cognitively impaired patients. As several rating scales have been used to assess depression in PD (dPD), the Movement Disorder Society commissioned a task force to assess their clinimetric properties and make clinical recommendations regarding their use. A systematic literature review was conducted to explore the use of depression scales in PD and determine which scales should be selected for this review. The scales reviewed were the Beck Depression Inventory (BDI), Hamilton Depression Scale (Ham-D), Hospital Anxiety and Depression Scale (HADS), Zung Self-Rating Depression Scale (SDS), Geriatric Depression Scale (GDS), Montgomery-Asberg Depression Rating Scale (MADRS), Unified Parkinson's Disease Rating Scale (UPDRS) Part I, Cornell Scale for the Assessment of Depression in Dementia (CSDD), and the Center for Epidemiologic Studies Depression Scale (CES-D). Seven clinical researchers with clinical and research experience in the assessment of dPD were assigned to review the scales using a structured format. The most appropriate scale is dependent on the clinical or research goal. However, observer-rated scales are preferred if the study or clinical situation permits. For screening purposes, the HAM-D, BDI, HADS, MADRS, and GDS are valid in dPD. The CES-D and CSDD are alternative instruments that need validation in dPD. For measurement of severity of depressive symptoms, the Ham-D, MADRS, BDI, and SDS scales are recommended. Further studies are needed to validate the CSDD, which could be particularly useful for the assessment of severity of dPD in patients with comorbid dementia. To account for overlapping motor and nonmotor symptoms of depression, adjusted instrument cutoff scores may be needed for dPD, and scales to assess severity of motor symptoms (e.g., UPDRS) should also be included to help adjust for confounding factors. The HADS and the GDS include limited motor symptom assessment and may, therefore, be most useful in rating depression severity across a range of PD severity; however, these scales appear insensitive in severe depression. The complex and time-consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted.

show abstract

A Questionnaire Investigation of Anxiety and Depression in Early Dementia

Cited by 72 publications

References 18 publications

Symptoms of Anxiety and Depression in the Course of Cognitive Decline

Symptoms of Anxiety and Depression in the Course of Cognitive Decline

An exploratory study of the impact of group singing activities on lucidity, energy, focus, mood and relaxation for persons with dementia and their caregivers

Depression rating scales in Parkinson's disease: Critique and recommendations

Contact Info

Product

Resources

About